4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228343
Co-Chief Executive Officer sold 29,975 shares at an average $14.38 ($430,952)
From the SEC's structured data for this filing
Trades in this filing
Klee Justin B. · Co-Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-30 | Sale : show line 1 in the form | −29,775 | $14.37 | $427,950 | 3,325,501 | D |
| 2025-09-30 | Sale : show line 2 in the form | −200 | $15.01 | $3,002 | 3,325,301 | D |
| Open-market sales · 29,975 sh · avg $14.38 · $430,952 | ||||||
Loading xslF345X05/ownership.xml…